NeueHealth (NYSE:NEUE – Get Free Report) is one of 12 public companies in the “Hospital & medical service plans” industry, but how does it compare to its competitors? We will compare NeueHealth to similar companies based on the strength of its analyst recommendations, earnings, profitability, dividends, institutional ownership, valuation and risk.
Earnings and Valuation
This table compares NeueHealth and its competitors revenue, earnings per share and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
NeueHealth | $1.16 billion | -$1.15 billion | -0.04 |
NeueHealth Competitors | $60.22 billion | $1.28 billion | 6.88 |
NeueHealth’s competitors have higher revenue and earnings than NeueHealth. NeueHealth is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Analyst Recommendations
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
NeueHealth | 0 | 1 | 0 | 0 | 2.00 |
NeueHealth Competitors | 62 | 896 | 1819 | 55 | 2.66 |
NeueHealth presently has a consensus price target of $8.00, indicating a potential upside of 30.93%. As a group, “Hospital & medical service plans” companies have a potential upside of 14.54%. Given NeueHealth’s higher possible upside, analysts plainly believe NeueHealth is more favorable than its competitors.
Volatility and Risk
NeueHealth has a beta of 0.84, indicating that its share price is 16% less volatile than the S&P 500. Comparatively, NeueHealth’s competitors have a beta of 1.02, indicating that their average share price is 2% more volatile than the S&P 500.
Profitability
This table compares NeueHealth and its competitors’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
NeueHealth | -71.23% | N/A | -1.21% |
NeueHealth Competitors | -0.91% | -7.94% | -1.77% |
Institutional and Insider Ownership
63.9% of NeueHealth shares are owned by institutional investors. Comparatively, 77.9% of shares of all “Hospital & medical service plans” companies are owned by institutional investors. 64.3% of NeueHealth shares are owned by company insiders. Comparatively, 12.1% of shares of all “Hospital & medical service plans” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Summary
NeueHealth competitors beat NeueHealth on 9 of the 13 factors compared.
About NeueHealth
NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.